[A selective inhibitor of thromboxane biosynthesis (OKY-046) reduces the airway response to inhaled leukotriene D4 and acetylcholine in patients with asthma].
Yukawa
T
T
Yamai
T
T
Watanabe
S
S
Fukuda
M
M
Terashi
Y
Y
Fukuda
T
T
Makino
S
S
D000109:Acetylcholine / Q000494:pharmacology; D000179:Acrylates / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000503:physiopathology*; D001980:Bronchi / Q000187:drug effects*; D001985:Bronchial Provocation Tests; D005260:Female; D006801:Humans; D008297:Male; D008689:Methacrylates / Q000494:pharmacology*; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects; D013189:SRS-A / Q000494:pharmacology; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D000179:Acrylates; D008689:Methacrylates; D013189:SRS-A; D013930:Thromboxane-A Synthase; C034364:ozagrel; D000109:Acetylcholine